Spectral Medical Inc. (OTCMKTS:EDTXF) Short Interest Up 8.8% in March

Spectral Medical Inc. (OTCMKTS:EDTXF) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 71,500 shares, an increase of 8.8% from the March 15th total of 65,700 shares. Based on an average daily volume of 86,000 shares, the short-interest ratio is presently 0.8 days.

Spectral Medical Price Performance

Shares of Spectral Medical stock remained flat at $0.32 during trading hours on Tuesday. Spectral Medical has a twelve month low of $0.17 and a twelve month high of $0.50. The company has a market capitalization of $90.07 million, a PE ratio of -8.08 and a beta of 0.81. The business has a 50-day moving average of $0.37 and a 200 day moving average of $0.32.

Spectral Medical (OTCMKTS:EDTXF) last announced its earnings results on Thursday, March 28th. The company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $0.27 million for the quarter.

Spectral Medical Company Profile

Spectral Medical Inc, together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.